Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Carisma Therapeutics Inc. (SESN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Kelly Steven (President and CEO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 600,000 options to buy
@ $7.25, valued at
$4.4M
|
|
| 06/08/2023 |
4
| ZWEIFACH SANFORD S (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 38,700 options to buy
@ $7.25, valued at
$280.6k
|
|
| 06/08/2023 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 238,000 options to buy
@ $7.25, valued at
$1.7M
|
|
| 06/08/2023 |
4
| Torok Michael (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 38,700 options to buy
@ $7.25, valued at
$280.6k
|
|
| 06/08/2023 |
4
| Klichinsky Michael (Chief Scientific Officer) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 238,000 options to buy
@ $7.25, valued at
$1.7M
|
|
| 06/08/2023 |
4
| Ugwumba Chidozie (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 38,700 options to buy
@ $7.25, valued at
$280.6k
|
|
| 06/08/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 38,700 options to buy
@ $7.25, valued at
$280.6k
|
|
| 03/09/2023 |
4
| Kelly Steven (President and CEO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 625,797 options to buy
@ $0.63, valued at
$394.3k
Granted 415,968 options to buy
@ $1.46, valued at
$607.3k
|
|
| 03/09/2023 |
4
| Ugwumba Chidozie (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 2,215,877 shares
@ $0 |
|
| 03/09/2023 |
4
| Hodits Regina (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 2,297,546 shares
@ $0 |
|
| 03/09/2023 |
4
| Klichinsky Michael (Chief Scientific Officer) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 484,347 shares
@ $0
Granted 56,982 options to buy
@ $0.11, valued at
$6.3k
Granted 75,976 options to buy
@ $0.63, valued at
$47.9k
Granted 112,064 options to buy
@ $1.46, valued at
$163.6k
|
|
| 03/09/2023 |
4
| Morris Richard Steven (CFO) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 331,114 options to buy
@ $1.46, valued at
$483.4k
|
|
| 03/09/2023 |
4
| Torok Michael (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 51,250 shares
@ $0
Granted 319,991 shares
@ $0
Granted 50,000 shares
@ $0 |
|
| 03/09/2023 |
4
| ZWEIFACH SANFORD S (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 413 shares
@ $0
Granted 184,621 options to buy
@ $1.46, valued at
$269.5k
|
|
| 03/09/2023 |
4
| Morrison Briggs (Director) has filed a Form 4 on Carisma Therapeutics Inc.|
Txns:
| Granted 12,175 shares
@ $0
Granted 63,310 options to buy
@ $0.68, valued at
$43.1k
Granted 34,189 options to buy
@ $1.46, valued at
$49.9k
|
|
| 03/06/2023 |
4
| Sullivan Mark (General Counsel & Secretary) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 100,978 shares
@ $0.587, valued at
$59.3k
Exercised 185,000 shares
@ $0.587, valued at
$108.6k
Sold 73,361 shares
@ $0.587, valued at
$43.1k
Exercised 113,175 shares
@ $0.587, valued at
$66.4k
Sold 44,879 shares
@ $0.587, valued at
$26.3k
|
|
| 03/06/2023 |
4
| MacDonald Glen C (Chief Technology Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 76,247 shares
@ $0.587, valued at
$44.8k
Exercised 183,317 shares
@ $0.587, valued at
$107.6k
Sold 60,237 shares
@ $0.587, valued at
$35.4k
Exercised 102,975 shares
@ $0.587, valued at
$60.4k
Sold 33,888 shares
@ $0.587, valued at
$19.9k
|
|
| 03/06/2023 |
4
| Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 17,289 shares
@ $0.587, valued at
$10.1k
|
|
| 03/06/2023 |
4
| Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 208,923 shares
@ $0.587, valued at
$122.6k
Exercised 606,800 shares
@ $0.587, valued at
$356.2k
Sold 278,564 shares
@ $0.587, valued at
$163.5k
|
|
| 03/06/2023 |
4
| Forbes Monica (CFO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 154,266 shares
@ $0.587, valued at
$90.6k
Exercised 190,375 shares
@ $0.587, valued at
$111.8k
Sold 93,279 shares
@ $0.587, valued at
$54.8k
Exercised 180,750 shares
@ $0.587, valued at
$106.1k
Sold 98,304 shares
@ $0.587, valued at
$57.7k
|
|
| 02/23/2023 |
4
| Sullivan Mark (General Counsel & Secretary) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 39,831 shares
@ $0.5873, valued at
$23.4k
|
|
| 02/23/2023 |
4
| Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 7,159 shares
@ $0.5873, valued at
$4.2k
|
|
| 02/23/2023 |
4
| Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 53,727 shares
@ $0.5873, valued at
$31.6k
|
|
| 02/23/2023 |
4
| Forbes Monica (CFO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 61,862 shares
@ $0.5873, valued at
$36.3k
|
|
| 02/23/2023 |
4
| MacDonald Glen C (Chief Technology Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Sold 25,927 shares
@ $0.5873, valued at
$15.2k
|
|
| 06/24/2022 |
4
| Duker Jay S. (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 65,000 options
@ $0.79, valued at
$51.4k
|
|
| 06/24/2022 |
4
| Honig Peter (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 65,000 options
@ $0.79, valued at
$51.4k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Keyes Jason A (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 65,000 options
@ $0.79, valued at
$51.4k
|
|
| 06/24/2022 |
4
| Bourdow Carrie L. (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 65,000 options
@ $0.79, valued at
$51.4k
|
|
| 06/03/2022 |
4
| Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 95,500 options to buy
@ $0.5834, valued at
$55.7k
|
|
| 02/23/2022 |
4
| Sullivan Mark (General Counsel & Secretary) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 339,525 shares
@ $0 |
|
| 02/23/2022 |
4
| Ryu Elly (Principal Accounting Officer) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 86,300 shares
@ $0 |
|
| 02/23/2022 |
4
| Cannell Thomas R (President and CEO) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 606,800 shares
@ $0 |
|
|
|
|